PS1-11: Feasibility of Prospective Surveillance for Adverse Drug Events – Lessons Learned from a 12-Month Pilot Study

BACKGROUND/AIMS: When new medications are introduced, safety data are often sparse. Health plan data may be useful for active surveillance for adverse events. We conducted a 12-month pilot study to demonstrate the feasibility of prospective active surveillance using data from several large health in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dublin, Sascha, Avery, Taliser, Cheetham, Craig, Davis, Robert, Kulldorff, Martin, Li, Lingling, Liu, Liyan, Brown, Jeffrey
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Marshfield Clinic 2011
Gaiak:
SELECTED ABSTRACTS - HMORN 2011: Pharmacoepidemiology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251478/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2011.1020.ps1-11
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak